Tokioka-akagi Tomoko | Biometrics Department Yamanouchi Pharmaceutical Co. Ltd.
スポンサーリンク
概要
関連著者
-
FUJIMORI Akira
Applied Pharmacology Research Laboratories, Drug Discovery Research, Astellas Pharma Inc.
-
Fujimori Akira
アステラス製薬研究本部薬理研究所
-
Fujimori Akira
Applied Pharmacology Research Laboratories Drug Discovery Research Astellas Pharma Inc.
-
Yanagisawa I
Yamanouchi Pharmaceutical Co. Ltd. Ibaraki Jpn
-
Yanagisawa Isao
Institute For Drug Discovery Research Yamanouchi Pharmaceutical Co.
-
Yanagisawa Isao
山之内製薬
-
Shibasaki Masayuki
Institute For Drug Discovery Research Yamanouchi Pharmaceutical Co.
-
Shibasaki Masayuki
General Education Courses Faculty Of Engineering Toyo University
-
Inagaki Osamu
Institute For Drug Discovery Research Yamanouchi Pharmaceutical Co.
-
Fujimori Akira
Institute For Drug Discovery Research Yamanouchi Pharmaceutical Co.
-
TOKIOKA-AKAGI Tomoko
Biometrics Department, Yamanouchi Pharmaceutical Co., Ltd.
-
Tokioka-akagi Tomoko
Biometrics Department Yamanouchi Pharmaceutical Co. Ltd.
-
Matsuda-satoh Yasuko
Institute For Drug Discovery Research Yamanouchi Pharmaceutical Co.
-
UCHIDA Wataru
Institute for Drug Discovery Research, Yamanouchi Pharmaceutical Co., Ltd.
-
Uchida W
Yamanouchi Pharmaceutical Co. Ltd. Ibaraki Jpn
-
Uchida Wataru
Institute For Drug Discovery Research Yamanouchi Pharmaceutical Co. Ltd.
-
Fujimori Akira
Institute For Drug Discovery Research Yamanouchi Pharmaceutical Co. Ltd.
-
TOKIOKA Tomoko
(Present address)Clinical Development Coordination Department, Yamanouchi Pharmaceutical Co., Ltd.,
-
TOKIOKA-AKAGI TOMOKO
Clinical Development Coordination Department, Yamanouchi Pharmaceutical Co., Ltd.
著作論文
- Effects of YM358,an Angiotensin II Type 1 (AT_1) Receptor Antagonist, and Enalapril on Blood Pressure and Vasoconstriction in Two Renal Hypertension Models
- Effects of Angiotensin II Type 1 Receptor Antagonist, YM358, on Cardiac Hypertrophy and Dysfunction after Myocardial Infarction in Rats
- Comparison of the Angiotensin II Type 1-Receptor Antagonist YM358 and the Angiotensin-Converting Enzyme Inhibitor Enalapril in Rats With Cardiac Volume Overload